REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2018 | $10,000 | -37.5% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $16,000 | 0.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | -15.8% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $19,000 | +26.7% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | -6.2% | 15,000 | +50.0% | 0.00% | 0.0% |
| Q1 2017 | $16,000 | -27.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $22,000 | -33.3% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $33,000 | +13.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $29,000 | -68.8% | 10,000 | -6.6% | 0.00% | -66.7% |
| Q4 2015 | $93,000 | – | 10,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,790,476 | $41,544,000 | 4.18% |
| Foresite Capital Management II, LLC | 893,781 | $9,796,000 | 3.44% |
| Abingworth LLP | 327,350 | $3,588,000 | 1.63% |
| Cormorant Asset Management, LP | 896,522 | $9,826,000 | 1.31% |
| Trellus Management Company, LLC | 80,000 | $877,000 | 0.99% |
| ORACLE INVESTMENT MANAGEMENT INC | 741,804 | $8,130,000 | 0.99% |
| WEDBUSH SECURITIES INC | 93,165 | $1,021,000 | 0.19% |
| SABBY MANAGEMENT, LLC | 344,667 | $3,778,000 | 0.14% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,260 | $222,000 | 0.13% |
| Perceptive Advisors | 200,000 | $2,196,000 | 0.13% |